Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of TJ0113 capsules in sarcopenia
CTR20262116Phase 2Active
- Sponsor
- Tianji Jishi Biotechnology
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TJ0113 in Sarcopenia, sponsored by Tianji Jishi Biotechnology. Started Jun 2026; status: active.
02
Drugs
TJ0113
03
Conditions
Sarcopenia
Beyond the preview
Go deeper on CTR20262116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262116.